FDA Hearing, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds (May 31, 2019)

Information and materials for this event are available from the FDA at:

May 31, 2019 Erika Edwards previewed the first public FDA hearing on cannabis and cannabis-derived compounds for NBC News.

2nd Annual CMCR Symposium Cannabis and Health
Pragmatics, Priorities, Possibilities

Robert Fitzgerald, Ph.D.
Senate Caucus on International Narcotics Control
(October 23, 2019)

Igor Grant, MD
House Committee on Veterans’ Affairs (June 20, 2019)

Igor Grant, M.D.
FDA Hearing: Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds
(May 31, 2019)

Igor Grant, MD

Marijuana as Medicine: Can We See Past the Smoke?
North American Cannabis Summit presentation January 2019 (PDF)

Igor Grant, MD

Introduction/Overview
CMCR Symposium, June 2018

Daniele Piomelli, MD, PhD, PharmD

The health impact of cannabis
CMCR Symposium, June 2018

Ziva Cooper, PhD

Therapeutic potential of cannabis for pain alone and as an adjunct to opioids
CMCR Symposium, June 2018